Immunic (IMUX) vs Milestone Pharmaceuticals (MIST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immunic (IMUX) has outperformed Milestone Pharmaceuticals (MIST) over the past year, losing 13.3% versus a loss of 63.6%. Over five years, MIST leads with a -87.2% price change compared with -91.2% for IMUX. Immunic is the larger company by market cap ($103.2 million vs $88.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMUX | MIST |
|---|---|---|
| Share price | $7.56 | $0.7121 |
| Market cap | $103.15M | $88.66M |
| 1-day change | -0.92% | -5.96% |
| YTD return | +42.88% | -62.51% |
| 1-year return | -13.30% | -63.60% |
| 5-year return | -91.20% | -87.17% |
| EPS (TTM) | $-3.83 | $-0.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.43 | $3.06 |
| 52-week low | $5.06 | $0.7096 |
| Distance from 52-week high | -56.63% | -76.73% |
| Average volume | 277.39K | 1.39M |
| Shares outstanding | 13.64M | 124.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMUX has outperformed MIST by 50.3 percentage points over the past year.
IMUX vs MIST FAQ
Which is bigger, Immunic or Milestone Pharmaceuticals?
Immunic (IMUX) is larger, with a market capitalization of $103.15M compared with $88.66M for Milestone Pharmaceuticals (MIST).
Which stock has performed better over the past year, IMUX or MIST?
IMUX returned -13.30% over the past 12 months, compared with -63.60% for MIST (price return, excluding dividends). Past performance does not predict future results.
Are Immunic and Milestone Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.